Amneal Pharmaceuticals, Inc.
AMRX
$10.83
$0.838.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 75.28M | 61.63M | 112.42M | 77.26M | 47.22M |
| Total Receivables | 849.27M | 800.29M | 808.56M | 786.23M | 803.38M |
| Inventory | 608.97M | 601.43M | 612.45M | 596.36M | 575.62M |
| Prepaid Expenses | 41.53M | 40.52M | 46.50M | 49.11M | 53.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.64M | 6.58M | 7.87M | 4.34M | 5.85M |
| Total Current Assets | 1.58B | 1.51B | 1.59B | 1.51B | 1.49B |
|
|
|||||
| Total Current Assets | 1.58B | 1.51B | 1.59B | 1.51B | 1.49B |
| Net Property, Plant & Equipment | 546.29M | 522.75M | 523.69M | 532.90M | 528.94M |
| Long-term Investments | 597.41M | 597.50M | 597.44M | 598.32M | 598.53M |
| Goodwill | 597.41M | 597.50M | 597.44M | 598.32M | 598.53M |
| Total Other Intangibles | 649.55M | 689.14M | 732.38M | 780.19M | 819.94M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 28.41M | 21.65M | 24.21M | 18.34M | 24.57M |
| Total Assets | 3.42B | 3.37B | 3.50B | 3.46B | 3.51B |
|
|
|||||
| Total Accounts Payable | 206.98M | 194.07M | 259.84M | 236.92M | 201.78M |
| Total Accrued Expenses | 292.68M | 262.20M | 307.31M | 279.18M | 268.37M |
| Short-term Debt | 290.00M | 290.00M | 100.00M | 140.00M | 179.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 45.41M | 47.54M | 240.26M | 241.02M | 272.65M |
| Total Finance Division Other Current Liabilities | 272.07M | 282.02M | 222.36M | 198.08M | 192.56M |
| Total Other Current Liabilities | 272.07M | 282.02M | 222.36M | 198.08M | 192.56M |
| Total Current Liabilities | 1.11B | 1.08B | 1.13B | 1.10B | 1.11B |
|
|
|||||
| Total Current Liabilities | 1.11B | 1.08B | 1.13B | 1.10B | 1.11B |
| Long-Term Debt | 2.15B | 2.15B | 2.16B | 2.17B | 2.18B |
| Short-term Debt | 290.00M | 290.00M | 100.00M | 140.00M | 179.00M |
| Capital Leases | 100.08M | 87.98M | 91.09M | 94.03M | 95.92M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 115.90M | 106.86M | 163.33M | 135.81M | 126.14M |
| Total Liabilities | 3.47B | 3.42B | 3.55B | 3.49B | 3.51B |
|
|
|||||
| Common Stock & APIC | 557.76M | 548.94M | 563.31M | 556.33M | 548.80M |
| Retained Earnings | -572.45M | -594.87M | -607.06M | -575.98M | -575.83M |
| Treasury Stock & Other | -97.43M | -85.74M | -65.51M | -73.78M | -30.44M |
| Total Common Equity | -112.12M | -131.67M | -109.27M | -93.43M | -57.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -112.12M | -131.67M | -109.27M | -93.43M | -57.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 65.39M | 72.28M | 64.73M | 59.75M | 53.40M |
| Total Equity | -46.73M | -59.39M | -44.54M | -33.68M | -4.07M |
|
|
|||||